Author

Ryo Shimizu

Joint Research Center for Human Retrovirus Infection, Kumamoto UniversityPrimary ORCID profile (0009-0001-5962-1106 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ryo ShimizuiD2 papers · Kyoto University

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

Akatsuki SaitoiD· 2 shared Michael Jonathan· 2 shared Terumasa IkedaiD· 2 shared Akifumi Takaori‐KondoiD· 1 shared Alfredo A. HinayiD· 1 shared Anon H. KosakaiD· 1 shared Arnon PlianchaisukiD· 1 shared Ayaka SakamotoiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Akatsuki SaitoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

APOBEC3 antagonism fully explains HIV-1 Vif essentiality under interferon and differentiation conditions

Ryo Shimizu, Michael Jonathan, Hiromi Terasawa, Akatsuki Saito, Kazuaki Monde, Terumasa Ikeda

This study shows that HIV-1 Vif's essential role in infectivity under interferon and differentiation conditions is fully explained by its antagonism of APOBEC3 proteins, not other targets.

bioRxiv · Apr 17, 2026 · PreprintMicrobiology

A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity

Shuhei Tsujino, Masumi Tsuda, Sayaka Deguchi, Jumpei Ito, Taha Y. Taha, Hesham Nasser, Lei Wang, Julia Rosecrans, Rigel Suzuki, Saori Suzuki, Kumiko Yoshimatsu, Mélanie Ott, Terumasa Ikeda, Kei Sato, Kazuo Takayama, , Miki Kawano

This study identifies the non-spike R204P mutation in the SARS-CoV-2 Omicron XEC variant as a driver of increased inflammation and pathogenicity through NF-κB activation.

Nature Communications · Dec 14, 2025Peer-reviewedMicrobiology